CTKB stock

Cytek Biosciences Inc (CTKB) earnings · rev $201.5M

These earnings events as JSON? API free 100/day

Cytek Biosciences Inc (CTKB) is a medical devices company listed on US.

This CTKB earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.

Latest reported CTKB revenue for 2025-12-31 was $201.5M. Net income was -$66.5M. Revenue was up 0.5% from 2024-12-31 to 2025-12-31. CTKB currently screens at market cap $421.8M.

When the next CTKB 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.

The change that matters: Revenue was up 0.5% from 2024-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.

Not investment advice. Full CTKB research stays on the stock page; the tape stays on the quote page.

CTKB earnings FAQ

What are CTKB's latest revenue and net income?

Latest cached Cytek Biosciences Inc (CTKB) revenue for Dec 31, 2025 was $201.5M. Net income was -$66.5M. Statements: https://lician.com/financials/ctkb

What period does the latest CTKB earnings print cover?

The latest cached Cytek Biosciences Inc (CTKB) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.

How did CTKB revenue change from the prior cached period?

Cached Cytek Biosciences Inc (CTKB) revenue was up 0.5% from $200.5M (Dec 31, 2024) to $201.5M (Dec 31, 2025). Statements: https://lician.com/financials/ctkb

Where are CTKB earnings listed?

Cached earnings facts for Cytek Biosciences Inc (CTKB) are listed at https://lician.com/earnings/ctkb. Statements: https://lician.com/financials/ctkb

Not investment advice.

Full CTKB analysis